Patent details

EP1044680 Title: Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate

Basic Information

Publication number:
EP1044680
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP003030335
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
French Title of Invention:
Nouvelle méthode de traitement à l'aide d'un fort régime de dosage d'Amoxycillin et de Clavulanate de Potassium
German Title of Invention:
Neue Behandlungsmethode unter Verwendung einer hochdosierten Form von Amoxycillin und Kaliumclavulanat
SPC Number:

Dates

Filing date:
11/04/2000
Grant date:
11/06/2003
EP Publication Date:
11/06/2003
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/10/2000
EP B1 Publication Date:
11/06/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/04/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/04/2000
 
 

Name:
Beecham Pharmaceuticals (Pte) Limited
Address:
38 Quality Road, Jurong Industrial Estate, Jurong, Singapore 618809, Singapore (SG)

Agent

1

Name:
KIRKPATRICK SA / NV
From:
02/05/2018
Address:
AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
To:

2

Name:
OFFICE FREYLINGER S.A.
From:
20/08/2003
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:
02/05/2018

Inventor

1

Name:
Storm Kevin
Address:
United States (US)

2

Name:
Conley Creighton
Address:
United States (US)

3

Name:
Roush John
Address:
United States (US)

Priority

1

Priority Number:
129074 P
Priority Date:
13/04/1999
Priority Country:
United States (US)

2

Priority Number:
150727 P
Priority Date:
25/08/1999
Priority Country:
United States (US)

3

Priority Number:
159813 P
Priority Date:
15/10/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/20;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/04/2019
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages
02/05/2018 Request For Change 2